| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017631723 |
| P356 | DOI | 10.1007/S00726-007-0604-2 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00726-007-0604-2 |
| P698 | PubMed publication ID | 17978889 |
| P2093 | author name string | Wei J | |
| Ye Y | |||
| Dai X | |||
| Gao Q | |||
| P2860 | cites work | Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists | Q45040354 |
| Insights from modeling the tertiary structure of human BACE2. | Q45097653 | ||
| Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide | Q45121648 | ||
| The discovery and synthesis of novel adenosine receptor (A(2A)) antagonists | Q45266824 | ||
| Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands | Q45417201 | ||
| Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein | Q46741746 | ||
| Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists | Q46775737 | ||
| Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives | Q46780364 | ||
| Molecular insights of SAH enzyme catalysis and implication for inhibitor design | Q47179774 | ||
| Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists. | Q48561677 | ||
| Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. | Q51661127 | ||
| Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. | Q51932839 | ||
| Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine | Q72622175 | ||
| Prediction of the tertiary structure of a caspase-9/inhibitor complex | Q73616626 | ||
| 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design | Q79791554 | ||
| 3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists | Q79852305 | ||
| Molecular modeling studies of peptide drug candidates against SARS | Q80202900 | ||
| Computational studies of the binding mechanism of calmodulin with chrysin | Q80374541 | ||
| Anti-SARS drug screening by molecular docking | Q83821348 | ||
| Molecular tinkering of G protein-coupled receptors: an evolutionary success | Q24534016 | ||
| Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor | Q24612312 | ||
| Medicinal chemistry of A2A adenosine receptor antagonists | Q28207752 | ||
| International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors | Q28209239 | ||
| 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility | Q28213414 | ||
| Modeling the tertiary structure of human cathepsin-E | Q28246353 | ||
| Adenosine A2A receptors and neuroprotection | Q28254683 | ||
| Molecular therapeutic target for type-2 diabetes | Q28298044 | ||
| Role of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues | Q28343911 | ||
| Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists | Q28370203 | ||
| 8-(Sulfostyryl)xanthines: water-soluble A2A-selective adenosine receptor antagonists. | Q32049468 | ||
| A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator | Q33333805 | ||
| Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications | Q33939663 | ||
| Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus | Q34005852 | ||
| Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | Q34307295 | ||
| KW-6002 (Kyowa Hakko Kogyo). | Q34379369 | ||
| Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase | Q34390896 | ||
| Inhibitor design for SARS coronavirus main protease based on "distorted key theory". | Q34608049 | ||
| Agaritine and its derivatives are potential inhibitors against HIV proteases | Q34628567 | ||
| Structural bioinformatics and its impact to biomedical science | Q35848051 | ||
| Techniques: Recent developments in computer-aided engineering of GPCR ligands using the human adenosine A3 receptor as an example | Q35998183 | ||
| Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides | Q36513137 | ||
| Progress in computational approach to drug development against SARS. | Q36683902 | ||
| Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin | Q40807186 | ||
| Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice | Q40862031 | ||
| Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes. | Q41056524 | ||
| Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease | Q41622546 | ||
| Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP. | Q42622708 | ||
| Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases | Q43176466 | ||
| Molecular modeling the human A1 adenosine receptor and study of the mechanisms of its selective ligand binding. | Q44240925 | ||
| Molecular modeling of the human A2a adenosine receptor | Q44510272 | ||
| Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points | Q44904083 | ||
| Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor | Q44922184 | ||
| Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists | Q45007079 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 389-396 | |
| P577 | publication date | 2007-11-05 | |
| P1433 | published in | Amino Acids | Q15757015 |
| P1476 | title | Computational studies of the binding modes of A 2A adenosine receptor antagonists | |
| P478 | volume | 35 |
| Q52665081 | In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease. | cites work | P2860 |
Search more.